Quantcast

Latest pharmaceutical industry Stories

2014-07-17 08:28:30

Unprecedented High Drug Costs to Force Major Financial Tradeoffs for State Budgets ST. LOUIS, July 17, 2014 /PRNewswire/ -- State legislatures will need to find billions in their budgets to purchase costly new hepatitis C therapy, according to a new state-by-state analysis released today by Express Scripts (NASDAQ: ESRX). http://photos.prnewswire.com/prnvar/20080827/EXPRESSSCRIPTSLOGO More than 750,000 Americans with chronic hepatitis C receive state-funded healthcare through Medicaid or the...

2014-07-17 08:28:25

ANDERNACH, Germany, July 17, 2014 /PRNewswire/ -- - LTS: market leader in transdermal patches completely acquired by dievini Hopp The supervisory board ("Aufsichtsrat") and management board ("Vorstand") of LTS have concluded the assessment of strategic options for the future development of the LTS group. LTS developed innovative, value oriented growth strategies identifying also the prerequisites for the successful strategy implementation. Meanwhile, LTS's major...

2014-07-17 08:28:14

LONDON, July 17, 2014 /PRNewswire/ -- PharmaBoardroom's "Healthcare and Life Sciences Review Poland 2014 [http://pharmaboardroom.com/country_reports/poland-2 ]", is now available for free download [http://pharmaboardroom.com/country_reports/poland-2 ]. The report [http://pharmaboardroom.com/country_reports/poland-2 ] explores one of Europe's largest pharma markets, and looks at the delicate balance between a strong and growing economy, and healthcare legislation that many...

2014-07-17 04:20:56

GENEVA, July 17, 2014 /PRNewswire/ -- MPP forges first agreement with a Chinese manufacturer Desano; and with Cipla, Mylan and Micro Labs; Extends Collaborations with Aurobindo, Laurus Labs and Emcure Three days before the start of the 20th International AIDS Conference in Melbourne, Australia, the Medicines Patent Pool (MPP) announced seven new sub-licensing agreements for the manufacture of generic HIV medicines, atazanavir (ATV) and dolutegravir (DTG). The...

2014-07-17 04:20:49

LUGANO, Switzerland and TOKYO, July 17, 2014 /PRNewswire/ -- Under the exclusive agreement, Chugai Pharma Marketing gains rights for the marketing of palonosetron in the UK and NEPA in the UK and in Ireland from Helsinn Group, strengthening the existing alliance between the companies in therapeutic area of supportive cancer care. Helsinn, the Swiss Group focused on building quality cancer care, and Chugai Pharmaceutical Co., Ltd. today announced that exclusive rights to...

2014-07-16 20:22:18

LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: In-Vitro Diagnostics Market Outlook 2018 https://www.reportbuyer.com/product/2080563/In-Vitro-Diagnostics-Market-Outlook-2018.html Driven by factors, such as increasing prevalence of chronic diseases, rising demand for POCT and technological advancements in the global market, the IVD market is going through a very exciting phase. Presently, the market is dominated by developed countries;...

2014-07-16 16:24:01

ABERDEEN, Scotland and SINGAPORE, July 16, 2014 /PRNewswire/ -- TauRx Therapeutics Ltd [http://www.taurx.com ] announced it has achieved its target enrollment of 833 subjects into one of its two ongoing multi-center Phase III clinical trials of LMTX(TM) [http://taurx.com/lmtx-for-ad ], a tau aggregation inhibitor, for the treatment of Alzheimer's Disease [AD]. This placebo-controlled clinical trial (Protocol TRx-237-015 [http://taurx.com/015-clinical-study.html ]) has...

2014-07-16 12:27:23

COSTA MESA, Calif., July 16, 2014 /PRNewswire-iReach/ -- WCCT Global, a contract research organization headquartered in Southern Californian announced today the successful completion of a large phase I clinical trial. The study protocol required that WCCT Global enroll 180 patients that would stay in their phase I Clinical Pharmacology Unit for an extended period of time. WCCT Global was able to randomize and accommodate all the needed patient cohorts without delays. WCCTG...

2014-07-16 12:24:29

Lengthy Authorization Process for Imports Could Spur Investment in Local Production, According to Findings from Decision Resources Group BURLINGTON, Mass., July 16, 2014 /PRNewswire/ -- Decision Resources Group finds that Turkey continues to hold appeal for multinational pharmaceutical companies due to its large domestic market and strategic location as a gateway to Europe, the Middle East and Africa, but that interest is being tested. Marketing authorization that stretches into years,...

2014-07-16 08:29:36

FREDERICK, Md., July 16, 2014 /PRNewswire/ -- ImQuest Pharmaceuticals was recently notified by the US Food and Drug Administration of the approval of its Investigational New Drug (IND) application to study the safety in Phase 1 clinical trials of its vaginal gel containing the nonnucleoside reverse transcriptase HIV Inhibitor IQP-0528. Preclinical studies have shown that IQP-0528 is highly effective against virus strains found throughout the world, prevents HIV transmission in...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related